RHB Group Research

Broker's Calls

RHB remains 'neutral' on IREIT Global; says valuations are 'fair'

In its 1QFY2023 update, IREIT reported a portfolio occupancy of 87.0%, down 1.3 percentage points q-o-q, as at March 31.

Broker's Calls

RHB remains upbeat on accommodation build group Centurion Corp, maintains 'buy'

Analyst Alfie Yeo kept his target price unchanged at 51 cents.
Analysts like Keppel REIT after posting 'positive operating metrics' for 1QFY2023 - THE EDGE SINGAPORE

Broker's Calls

Analysts like Keppel REIT after posting 'positive operating metrics' for 1QFY2023

The REIT recorded a positive rental reversion rate of 9.3% for the 1QFY2023 ended March.

Broker's Calls

RHB trims Frencken's TP to $1.14 on high inventory and soft demand

The chip sector is expected to be weak in 1H2023 from soft consumption of electronics.
RHB is keeping Sheng Siong in its cart - THE EDGE SINGAPORE

Broker's Calls

RHB is keeping Sheng Siong in its cart

RHB likes Sheng Siong for defensive qualities, strong balance sheet, attractive dividends, store expansion, etc.

Broker's Calls

External factors dragged down CPO prices, RHB maintains 'neutral' on plantation sector

Despite moderating upside risks, there are still supportive factors that should keep prices relatively stable.

Broker's Calls

Return of tourism and cheap rides expected to rev up ComfortDelGro's outlook

Return of tourism and cheap rides expected to rev up ComfortDelGro’s outlook; RHB keeps buy call

Broker's Calls

RHB remains positive on Marco Polo Marine’s prospects, ups TP to 6 cents

RHB's Alfie Yeo has upped his earnings estimates for FY2023 and FY2024 as he remains upbeat on the company's long-term growth.
RHB maintains 'buy' on Raffles Medical Group following strong revenue and China's reopening - THE EDGE SINGAPORE

Broker's Calls

RHB maintains 'buy' on Raffles Medical Group following strong revenue and China's reopening

Covid-19 may be behind, but RHB still sees a lot of life in Raffles Medical Group.
×